USPTO trademark

BYRTREYA

Under examinationUSPTOWord markClass 5

"BYRTREYA" is a word mark owned by Regeneron Pharmaceuticals, Inc., filed at the USPTO on October 6, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Regeneron Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
BYRTREYA trademark as filed
As filed with the USPTO
Status
Under examination
Since October 6, 2026
Filed
October 6, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50146185
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns BYRTREYA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Regeneron Pharmaceuticals, Inc.

REGN · Tarrytown, United States

709 trademarks in the portfolioView company

Representative

Jeffrey J. Scepanski

Ruggiero McAllister & McMahon LLC

Goods and services

What the mark covers

The products and services BYRTREYA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About BYRTREYA

Who owns the trademark "BYRTREYA"?

The USPTO trademark "BYRTREYA" (application 50146185) is owned by Regeneron Pharmaceuticals, Inc.

What is the status of "BYRTREYA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BYRTREYA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a11679-a7d5-757d-99f0-62f480789dd9
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a11679-a7d5-757d-99f0-62f480789dd9",
  "object": "trademark",
  "mark_text": "BYRTREYA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50146185",
  "filing_date": "2026-10-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Regeneron Pharmaceuticals, Inc.",
      "entity_id": "ent_019f286c-d59a-777d-b029-6ae9c6959369"
    }
  ]
}